瑞兴医药 (835553.OC)

+ 收藏

财务分析(报告期)(瑞兴医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年三季报2023年中报2022年年报2022年三季报2022年中报
主要指标:
 营业收入(元) 71,168,636.29150,758,427.8298,033,275.3666,301,489.54223,844,088.34140,774,499.0183,430,098.65
 营业利润(元) 636,243.392,273,707.101,939,240.942,002,947.698,081,725.6513,821,247.087,858,055.21
 利润总额(元) 538,334.962,258,427.711,943,956.531,967,663.288,081,515.9313,821,801.327,858,055.21
 净利润(元) 259,161.95569,984.811,694,475.521,410,409.624,579,065.769,271,940.135,048,749.86
 归属于母公司股东的净利润(元) 259,161.95569,984.811,694,475.521,410,409.624,579,065.769,271,940.135,048,749.86
盈利能力:
 销售毛利率(%) 21.9420.4220.6419.6116.2122.0119.37
 销售净利率(%) 0.360.381.732.132.056.596.05
 净资产收益率(%) 0.140.361.010.89---
 总资产报酬率ROA(%) 0.701.871.200.97---
 投入资本回报率ROIC(%) 0.741.961.591.124.535.583.25
营运能力:
 存货周转率(次) 1.152.331.080.42---
 应收账款周转率(次) 2.153.532.882.05---
 总资产周转率(次) 0.210.440.280.20---
偿债能力:
 资产负债率(%) 43.4946.7446.5446.5561.8156.5457.76
 股东权益比率(%) 56.5153.2653.4653.4538.1943.4642.24
 已获利息倍数(倍) 1.291.541.882.622.796.846.31
 流动比率 0.700.750.750.830.740.881.59
 速动比率 0.380.430.360.400.420.280.32
发展能力:
 营业收入增长率(%) 7.34-32.65-30.36-20.53-17.7236.4722.98
 营业利润增长率(%) -68.23-71.87-85.97-74.51-85.54161.76151.48
 税后利润增长率(%) -81.63-87.55-81.72-72.06-89.07108.10118.23
 净资产增长率(%) 0.1547.9728.9249.35-4.01-36.28
 总资产增长率(%) -5.276.114.8118.020.94--14.12

前瞻产业研究院